We are live on ! Find out more
NTRP

Neurotrope, Inc. Common
NTRP

Delisted

NTRP was delisted on the 1st of December, 2020.

Back to rankings

34 hedge funds and large institutions have $2.07M invested in Neurotrope, Inc. Common in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

10% more funds holding

Funds holding: 31 → 34 (+3)

2% more capital invested

Capital invested by funds: $2.03M → $2.07M (+$38.5K)

Holders
34
Holders Change
+3
Holders Change %
+9.68%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
4
Closed
3
Calls
$12K
Puts
–
Net Calls
+$12K
Net Calls Change
-$75K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$107K
2
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$39.5K
3
VF
Virtu Financial
New York
+$34.5K
4
FIA
FNY Investment Advisers
New York
+$28.8K
5
Two Sigma Investments
Two Sigma Investments
New York
+$21.7K

Top Sellers

Rank Fund Capital Flow
1
MA
MYDA Advisors
New York
-$89K
2
Squarepoint
Squarepoint
New York
-$58K
3
TRCT
Tower Research Capital (TRC)
New York
-$13.6K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$7.49K
5
TI
tru Independence
Oregon
-$2K

NTRP Hedge Fund Activity: Q3 2020 in Review

34 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Neurotrope, Inc. Common (NTRP) for Q3 2020, worth a combined $2.07M — up 1.9% from $2.03M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NTRP positions and 3 closed out — a net gain of 3 holders — while 8 added to existing stakes and 4 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $107K. The largest seller was MYDA Advisors, exiting entirely with an estimated $89K sold.

  • 34 institutional investors held Neurotrope, Inc. Common (NTRP) as of Q3 2020, up from 31 in Q2 2020.
  • Funds reported $2.07M of Neurotrope, Inc. Common stock for Q3 2020, up 1.9% quarter-over-quarter.
  • 6 funds opened new Neurotrope, Inc. Common positions in Q3 2020 and 3 closed out, a net change of +3 holders.
  • The largest Neurotrope, Inc. Common buyer in Q3 2020 was Renaissance Technologies, an estimated $107K added.
  • The largest Neurotrope, Inc. Common seller in Q3 2020 was MYDA Advisors, an estimated $89K sold.

Based on aggregated 13F filings for Q3 2020.